Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
At IFF, we bring unmatched expertise and forward-thinking, weight-management solutions, especially for those on GLP-1s and other anti-obesity medications
A: Retatrutide is a triple-agonist peptide that targets GLP1, GIP, and glucagon receptors
The starting dose used in phase 2 clinical trials has been low, with a gradual, pre-specified dose-escalation schedule over subsequent weeks to improve tolerability
The Real Bottleneck Is No Longer Discovery
Finally, future perspectives of these therapies are briefly discussed
If you are unsure whether you are reading units or mL, look at the syringe label
US$ 28.80
/product/05/3175523/1.jpg?6751)
US$ 27.44
US$ 25.31
US$ 22.91
